The 2025 Chery International User Summit Opens a New Chapter as AiMOGA Robotics Unveils Its Global Brand Strategy

In today’s rapidly evolving global industrial landscape, technological innovation has taken on…

Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting

AMT-253 is a potential first-in-class MUC18-directed ADC with a proprietary linker-payload design…

Wialon Announces Top 10 GPS Hardware Manufacturers for 2025

DUBAI, UAE, Oct. 19, 2025 /PRNewswire/ — Teltonika Telematics has once again been…

Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia

SHANGHAI, Oct. 19, 2025 /PRNewswire/ — Primary plasma cell leukemia (pPCL) is…

From Wellbeing to Academics: Why HK Parents Are Hitting Pause on Kids' Social Media and Device Use

Look Up Hong Kong-Ipsos survey of 651 parents backs a four-part plan…

From Presentation to Full-Service Reception: AiMOGA Robot Demonstrates "Human Assistant" Capabilities at the 2025 Chery Global Innovation Conference

WUHU, China, Oct. 19, 2025 /PRNewswire/ — At the 2025 Chery Global Innovation…

HKUST Holds Congregation 2025 Conferring Honorary Doctorates on Five Distinguished Leaders

HONG KONG, Oct. 19, 2025 /PRNewswire/ — The Hong Kong University of…

Global Sources Hong Kong Shows Phase II Officially Opens: AI Pavilion Debuts, Spotlighting Latest AI and Robotics Trends

HONG KONG, Oct. 18, 2025 /PRNewswire/ — The second phase of the…